Health and wellness products company USANA Health Sciences (NYSE:USNA) will be announcing earnings results this Tuesday after market hours. Here’s what investors should know.
USANA met analysts’ revenue expectations last quarter, reporting revenues of $213.7 million, up 6.7% year on year. It was a satisfactory quarter for the company, with an impressive beat of analysts’ EBITDA estimates but a miss of analysts’ gross margin estimates.
Is USANA a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting USANA’s revenue to grow 5.8% year on year to $226 million, a reversal from the 3.4% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.41 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. USANA has missed Wall Street’s revenue estimates three times over the last two years.
Looking at USANA’s peers in the personal care segment, some have already reported their Q4 results, giving us a hint as to what we can expect. e.l.f. Beauty delivered year-on-year revenue growth of 37.8%, beating analysts’ expectations by 6.4%, and Estée Lauder reported revenues up 5.6%, in line with consensus estimates. e.l.f. Beauty traded down 9.2% following the results while Estée Lauder was also down 16.8%.
Read our full analysis of e.l.f. Beauty’s results here and Estée Lauder’s results here.
There has been positive sentiment among investors in the personal care segment, with share prices up 3.7% on average over the last month. USANA is down 4.9% during the same time and is heading into earnings with an average analyst price target of $39 (compared to the current share price of $20.92).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.